-+ 0.00%
-+ 0.00%
-+ 0.00%

DNA X FY25 net loss widens to $20.7 million; operating loss grows to $5.4 million

PUBT·04/15/2026 01:35:29
Listen to the news
DNA X FY25 net loss widens to $20.7 million; operating loss grows to $5.4 million
  • DNA X posted 2025 net loss of $20.7 million.
  • Continuing-operations net loss widened to $8 million from $2.9 million, while revenue showed no revenue.
  • General and administrative expense climbed to $5.4 million from $3.1 million.
  • Completed acquisition of DNA X cryptocurrency trading platform in December 2025; closed sale of mobile device assets to NEXA on Jan. 23, 2026 for $15 million, including $13.5 million paid at close.
  • Outlook calls for growth in revenue, gross margin, profitability as platform exits monitoring and testing phase and begins marketing to public.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202604142134NEWSFILECNPR____20260414_292277_1) on April 15, 2026, and is solely responsible for the information contained therein.